Literature DB >> 24372624

The prognosis and treatment outcomes of patients with recurrent hepatocellular carcinoma after liver transplantation.

Young-Nam Roh1, Choon Hyuck David Kwon, Sanghyun Song, Milljae Shin, Jong Man Kim, Sungjoo Kim, Jae-Won Joh, Suk-Koo Lee.   

Abstract

Liver transplantation (LT) is performed in patients with hepatocellular carcinoma (HCC), but recurrent HCC after LT remains a problem. We retrospectively reviewed the data from 63 patients with recurrent HCC who underwent LT at a single institution between September 1996 and March 2011 to determine the prognosis of patients with recurrent HCC after LT. A survival analysis was performed with the preoperative data, histological findings, patterns of recurrence, and treatment methods. Univariate and multivariate analyses were performed to determine the factors associated with early (<1 yr) cancer-related death. The independent prognostic factors, according to the multivariate analysis, were recurrence within six months (hazards ratio [HR] = 4.557, p = 0.021) and initial multiple-organ involvement (HR = 5.494, p = 0.015). The survival rates of patients differed according to the treatment type. The combined treatment with local and systemic treatment resulted in increased survival even in patients with HCC recurrences involving multiple organs.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  locoregional treatment; mTOR inhibitor; metastasis; rapamycin; sorafenib

Mesh:

Year:  2013        PMID: 24372624     DOI: 10.1111/ctr.12286

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  11 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Authors:  Kyung-Suk Suh; Hae Won Lee
Journal:  Hepat Oncol       Date:  2015-01-12

Review 3.  Chemotherapy for hepatocellular carcinoma: The present and the future.

Authors:  Marco Le Grazie; Maria Rosa Biagini; Mirko Tarocchi; Simone Polvani; Andrea Galli
Journal:  World J Hepatol       Date:  2017-07-28

Review 4.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

5.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

6.  Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes.

Authors:  Robert Mahn; Farsaneh Sadeghlar; Alexandra Bartels; Taotao Zhou; Tobias Weismüller; Patrick Kupczyk; Carsten Meyer; Florian C Gaertner; Marieta Toma; Tim Vilz; Petra Knipper; Tim Glowka; Steffen Manekeller; Jörg Kalff; Christian P Strassburg; Maria A Gonzalez-Carmona
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

Review 7.  Hepatocellular carcinoma: A comprehensive review.

Authors:  Lisa P Waller; Vrushak Deshpande; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2015-11-18

8.  Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience.

Authors:  Lin Zhou; Li-Chao Pan; Yong-Gen Zheng; Guo-Sheng Du; Xiao-Qian Fu; Zhi-Dong Zhu; Ji-Yong Song; Zhi-Jia Liu; Xiang-Zheng Su; Wen Chen; De-Hua Zheng; Long-Long Suo; Shao-Zhen Yang
Journal:  Oncol Lett       Date:  2018-07-27       Impact factor: 2.967

9.  A National Survey of Hepatocellular Carcinoma Surveillance Practices Following Liver Transplantation.

Authors:  Avin Aggarwal; Helen S Te; Elizabeth C Verna; Archita P Desai
Journal:  Transplant Direct       Date:  2020-12-08

Review 10.  The management of post-transplantation recurrence of hepatocellular carcinoma.

Authors:  Luckshi Rajendran; Tommy Ivanics; Marco Paw Claasen; Hala Muaddi; Gonzalo Sapisochin
Journal:  Clin Mol Hepatol       Date:  2021-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.